Tirzepatide
11 stories
-
techRoche Deploys 3,500 Nvidia Blackwell GPUs for Drug Discovery
Roche accelerates pharmaceutical R&D with 3,500 Nvidia Blackwell GPUs, targeting obesity drugs and challenging Eli Lilly's market dominance.
-
healthGLP-1 Users Regain Minimal Weight After Stopping, Real-World Study Finds
A Cleveland Clinic study shows most patients regain only 0.5% of lost weight a year after stopping Ozempic or similar GLP-1 drugs.
-
healthOzempic Users Keep Off 25% of Lost Weight After Stopping
New study reveals weight regain patterns after discontinuing GLP-1 drugs like Ozempic and Wegovy, raising concerns over muscle loss and long-term health.